posted on 2019-11-15, 16:11authored byYiwen Liu, Marina Mendonca, Samantha Johnson, Helen O’Reilly, Peter Bartmann, Neil MarlowNeil Marlow, Dieter Wolke
<p><b>Background: </b>The Neurodevelopmental and Trauma
theories are two widely cited models of psychosis. A third – the Developmental
Risk Factor model – recognises the combined role of neurodevelopmental risks
and trauma.<b> </b>Our objective was to test these theories using preterm populations
as a natural experiment, given the high prevalence of neurodevelopmental
deficits and exposure to trauma.</p>
<p><b>Methods: </b>Two population-based preterm birth
cohorts, the Bavarian Longitudinal Study (BLS; N=399) and EPICure Study (N=184)
were included with term-born controls. Peer victimisation in childhood was
assessed by parent and child report and psychotic experiences (PE) were
assessed in early adulthood. Different models of psychosis were tested using
regression and mediation analyses.</p>
<p><b>Results: </b>There was support for the Trauma
and Developmental Risk Factor model in the BLS. Peer victimisation increased
the risk of PE for preterm and term-born participants equally (OR=4.87, 95% CI:
1.96 to 12.08). There was an indirect effect where preterm children were more
likely to be victimised, which subsequently increased risk of PE (β = 1.12
(SE=0.61), 95% CI: 0.11 to 2.48). The results were replicated in EPICure.</p>
<b>Conclusions: </b>Exposure to trauma
which is experienced more often by neurodevelopmental risk children rather than
neurodevelopmental risk per se increases the risk of psychotic experiences. The
findings are consistent with the Trauma model and Developmental Risk Factor
model. Interventions focused on reducing trauma may reduce the development of
PE.
Funding
Ms Liu has a funded PhD studentship by the Department of Psychology at the University of Warwick. BLS received funding from the German Federal Ministry of Education and Science (grants PKE24, JUG14, 01EP9504, and 01ER0801), and EPICure from Medical Research Council Programme (grant ref No.: MR/J01107X/1). Prof Marlow receives part funding from the Department of Health’s NIHR Biomedical Research Centre’s funding scheme at UCLH/UCL, and Prof Wolke, Prof Bartmann, Dr Mendonca and Prof Johnson from European Union’s Horizon 2020 research and innovation program (RECAP-Preterm) under grant agreement: 733280.